IP Library Granted Patent US 8,268,976
Granted Patent B2
US 8,268,976 · App. 12/352,535 · Granted Sep 18, 2012

Flea GABA receptor subunit nucleic acid molecules

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,268,976
App. No.
12/352,535
Granted
Sep 18, 2012
Kind
B2
Abstract

The present invention relates to flea GABA receptor subunit nucleic acid molecules; to flea GABA receptor subunit proteins encoded by such nucleic acid molecules; to antibodies raised against such proteins; and to compounds that inhibit the activity of such proteins. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. The present invention also includes therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and inhibitory compounds, particularly those that specifically inhibit flea GABA receptor subunit activity, as well as the use of such therapeutic compositions to treat animals.

Claims (9)

1. An isolated nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of:

a. a nucleotide sequence encoding a protein comprising an amino acid sequence at least 95% identical to SEQ ID NO:5, wherein the encoded protein binds to gamma-aminobutyric acid (GABA); and,

b. a nucleotide sequence fully complementary to the nucleotide sequence of (a).

2. A recombinant molecule comprising the nucleic acid molecule as set forth in claim 1 operatively linked to a transcription control sequence.

3. A recombinant virus comprising the nucleic acid molecule as set forth in claim 1 .

4. A recombinant cell comprising the nucleic acid molecule as set forth in claim 1 .

5. A composition comprising an excipient and the isolated nucleic acid molecule of claim 1 .

6. The composition of claim 5 , further comprising a component selected from the group consisting of an adjuvant and a carrier.

7. The isolated nucleic acid molecule of claim 1 , wherein the nucleic acid sequence is at least 95% identical to SEQ ID NO:7.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Dec 14, 2023
From: JPMORGAN CHASE BANK, N.A.
To: HESKA CORPORATION; DIAMOND ANIMAL HEALTH, INC.; HESKA IMAGING, LLC
Reel/Frame 066012/0887 →
SECURITY INTEREST Recorded Oct 24, 2017
From: HESKA CORPORATION; DIAMOND ANIMAL HEALTH, INC.; HESKA IMAGING, LLC
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 044636/0972 →
SECURITY AGREEMENT Recorded Jan 5, 2012
From: HESKA CORPORATION
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 027486/0020 →